Cargando…
Factors That Limit Positron Emission Tomography Imaging of P-Glycoprotein Density at the Blood–Brain Barrier
[Image: see text] Efflux transporters located at the blood–brain barrier, such as P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP), regulate the passage of many drugs in and out of the brain. Changes in the function and density of these proteins, in particular P-gp, may play a role...
Autores principales: | Kannan, Pavitra, Pike, Victor W., Halldin, Christer, Langer, Oliver, Gottesman, Michael M., Innis, Robert B., Hall, Matthew D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3675842/ https://www.ncbi.nlm.nih.gov/pubmed/23597242 http://dx.doi.org/10.1021/mp400011g |
Ejemplares similares
-
Serotonin and Norepinephrine Transporter Occupancy of Tramadol in Nonhuman Primate Using Positron Emission Tomography
por: Arakawa, Ryosuke, et al.
Publicado: (2018) -
Serotonin 1B receptor density mapping of the human brainstem using
positron emission tomography and autoradiography
por: Veldman, Emma R, et al.
Publicado: (2021) -
Factors Governing P-Glycoprotein-Mediated Drug–Drug Interactions at the Blood–Brain Barrier Measured with Positron Emission Tomography
por: Wanek, Thomas, et al.
Publicado: (2015) -
Serotonin transporter availability in adults with autism—a positron emission tomography study
por: Andersson, Max, et al.
Publicado: (2020) -
Pharmacokinetic modeling of P-glycoprotein function at the rat and human blood–brain barriers studied with (R)-[(11)C]verapamil positron emission tomography
por: Müllauer, Julia, et al.
Publicado: (2012)